Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXPAREL PK and Safety in Pediatric Spinal Surgery
NCT03485014Phase 1Completed
- Sponsor
- Pacira BioSciences
- Start
- Apr 2018
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of liposomal bupivacaine in postoperative pain, sponsored by Pacira BioSciences. Primary endpoint: Area Under the Curve of EXPAREL concentration. Started Apr 2018; status: completed.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03485014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03485014.